An estimated 10 million men age 40 and over have symptoms consistent with overactive bladder.

New research shows a combination of two medicines works better than using only one medication.

In men with overactive bladders and a benign enlarged prostate, researchers compared the use of Detrol LA, which works on the bladder, and Flomax, which works on the prostate, alone or in tandem.

Dr. Steven Kaplan, the study author at Weill Cornell Medical College, says, “The particular symptoms that we actually are concerned about is getting up at night to urinate, going frequently to the bathroom. This is actually the largest study ever done in men who have both a bladder problem and a prostate problem and we found that by treating both we have enhanced the quality of life in men with urinating symptoms.”

A new study found that avoidance of being overweight, and-- not having diabetes, high blood pressure, smoking, or excessive alcohol consumption were associated with both overall and what they term exceptional survival, meaning survival to a specific late age, like 85,  without major medical conditions or Alzheimer’s.

The big indicator of a long healthy life, though, was grip strength.

Dr. Bradley Willcox, the study author out of the Pacific Health Research Group, says, “Physical fitness is very important. You can think of gripping a tennis ball that tells you how strong your grip is, it is actually an indicator of how well you are built genetically and physically and it is also an indicator of how well trained you are in terms of physical fitness.”

The probability of exceptional survival to age 85 years was 55 percent with no risk factors but decreased to 9 percent with 6 or more risk factors.

And preliminary research suggests that testosterone replacement therapy for men with low testosterone levels appears to have little effect on the prostate gland, contrary to some reports that this therapy may be harmful.

Serum levels of testosterone decline with age, and changes because of that have been called "male menopause."

Now, treating the problem with testosterone replacement therapy has been thought to promote the development of prostate cancer.

But in the latest study of men who got testosterone replacement, no treatment-related change was observed in prostate tissue or in cancer rates or severity.

In 2005, a total of 2.3 million prescriptions were written for testosterone products.